- Home
- YIBO vs IPHA Comparison
YIBO vs IPHA Comparison
Compare YIBO & IPHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YIBO
- IPHA
- Stock Information
- Founded
- YIBO 2011
- IPHA 1999
- Country
- YIBO China
- IPHA France
- Employees
- YIBO N/A
- IPHA N/A
- Industry
- YIBO
- IPHA Biotechnology: Pharmaceutical Preparations
- Sector
- YIBO
- IPHA Health Care
- Exchange
- YIBO NYSE
- IPHA Nasdaq
- Market Cap
- YIBO 185.8M
- IPHA 150.9M
- IPO Year
- YIBO 2024
- IPHA 2019
- Fundamental
- Price
- YIBO $2.75
- IPHA $1.93
- Analyst Decision
- YIBO
- IPHA Strong Buy
- Analyst Count
- YIBO 0
- IPHA 1
- Target Price
- YIBO N/A
- IPHA $11.50
- AVG Volume (30 Days)
- YIBO 4.8M
- IPHA 50.9K
- Earning Date
- YIBO 03-21-2025
- IPHA 03-20-2025
- Dividend Yield
- YIBO N/A
- IPHA N/A
- EPS Growth
- YIBO N/A
- IPHA N/A
- EPS
- YIBO 0.17
- IPHA N/A
- Revenue
- YIBO $153,281,000.00
- IPHA $36,202,722.00
- Revenue This Year
- YIBO N/A
- IPHA N/A
- Revenue Next Year
- YIBO N/A
- IPHA $101.65
- P/E Ratio
- YIBO $18.34
- IPHA N/A
- Revenue Growth
- YIBO 5.90
- IPHA N/A
- 52 Week Low
- YIBO $1.80
- IPHA $1.29
- 52 Week High
- YIBO $17.47
- IPHA $3.51
- Technical
- Relative Strength Index (RSI)
- YIBO 45.68
- IPHA 56.50
- Support Level
- YIBO $3.11
- IPHA $1.72
- Resistance Level
- YIBO $3.96
- IPHA $1.92
- Average True Range (ATR)
- YIBO 1.59
- IPHA 0.10
- MACD
- YIBO -0.03
- IPHA 0.02
- Stochastic Oscillator
- YIBO 5.07
- IPHA 100.00
About YIBO PLANET IMAGE INTERNATIONAL LIMITED
Planet Image International Ltd is engaged in manufacturing and selling compatible toner cartridges. It develops and manufactures toner cartridges that are compatible with, and can be used in, a wide range of commonly available models of laser printers from different manufacturers, or compatible toner cartridges, on a white-label or third-party brand basis or under its self-owned brands. The company also sells its branded products through online sales channels under three brands, TrueImage, CoolToner, and AZtech. The company operates in North America, Europe, and Other countries.
About IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.